[HTML][HTML] Pancreatic gastrinoma, gastrointestinal stromal tumor (GIST), pheochromocytoma, and hürthle cell neoplasm in a patient with neurofibromatosis type 1: a case …
Objective: Rare co-existance of disease or pathology Background: Neurofibromatosis type 1
(NF1) is a multi-tumor syndrome in which affected patients develop malignancies that are …
(NF1) is a multi-tumor syndrome in which affected patients develop malignancies that are …
Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case …
AA Arif, PTW Kim, A Melck, A Churg… - … journal of case …, 2021 - pubmed.ncbi.nlm.nih.gov
BACKGROUND Neurofibromatosis type 1 (NF1) is a multi-tumor syndrome in which affected
patients develop malignancies that are rare in the overall population, such as tumors of …
patients develop malignancies that are rare in the overall population, such as tumors of …
Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case …
AA Arif, PTW Kim, A Melck, A Churg… - The American Journal …, 2021 - europepmc.org
BACKGROUND Neurofibromatosis type 1 (NF1) is a multi-tumor syndrome in which affected
patients develop malignancies that are rare in the overall population, such as tumors of …
patients develop malignancies that are rare in the overall population, such as tumors of …
Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case …
AA Arif, PTW Kim, A Melck, A Churg… - American Journal of …, 2021 - search.ebscohost.com
Objective: Rare co-existance of disease or pathology Background: Neurofibromatosis type 1
(NF1) is a multi-tumor syndrome in which affected patients develop malignancies that are …
(NF1) is a multi-tumor syndrome in which affected patients develop malignancies that are …